Aptose Biosciences Inc (APTO)

[Tartiaboy]

I believe that financial uncertainty is the primary factor holding APTO PPS down. Fear of dilution. Sometime within the next 6 months APTO needs to address this. I see several potential scenarios.

1. A dilution at the current PPS. That would likely be a major hit to current shareholders.

2. A dilution on positive news. Possible.

2. A non-dilutive loan tied to milestones. Several companies have taken this route.

3. Out-licensing of Lux, preferably for inflammation or other non-cancer indications. This may be possible if they get the G3 dosage data needed.

4. Help from Hanmi. Hanmi has helped SPPI and I see no reason why they might not help APTO. Especially since they have a huge vested interest in TUSP being successful.

One of these or combinations of these may be in play.